Matches in Wikidata for { <http://www.wikidata.org/entity/Q66064366> ?p ?o ?g. }
Showing items 1 to 35 of
35
with 100 items per page.
- Q66064366 description "clinical trial" @default.
- Q66064366 description "ensayu clínicu" @default.
- Q66064366 description "klinisch onderzoek" @default.
- Q66064366 description "клінічне випробування" @default.
- Q66064366 name "Pyrotinib in Combination With Capecitabine in Patients With Trastuzumab-resistant HER2-positive Advanced Breast Cancer" @default.
- Q66064366 name "Pyrotinib in Combination With Capecitabine in Patients With Trastuzumab-resistant HER2-positive Advanced Breast Cancer" @default.
- Q66064366 type Item @default.
- Q66064366 label "Pyrotinib in Combination With Capecitabine in Patients With Trastuzumab-resistant HER2-positive Advanced Breast Cancer" @default.
- Q66064366 label "Pyrotinib in Combination With Capecitabine in Patients With Trastuzumab-resistant HER2-positive Advanced Breast Cancer" @default.
- Q66064366 prefLabel "Pyrotinib in Combination With Capecitabine in Patients With Trastuzumab-resistant HER2-positive Advanced Breast Cancer" @default.
- Q66064366 prefLabel "Pyrotinib in Combination With Capecitabine in Patients With Trastuzumab-resistant HER2-positive Advanced Breast Cancer" @default.
- Q66064366 P1132 Q66064366-9E0E93AB-20DF-4CE8-9CDC-8D07B209966B @default.
- Q66064366 P1476 Q66064366-69F5E51F-FABD-4ECD-897D-D377CCAC3E7E @default.
- Q66064366 P2899 Q66064366-333DCC9B-B154-4DF4-9E5A-1C34C92CBEDE @default.
- Q66064366 P3098 Q66064366-1C35C0CF-7944-4827-AC69-4262D35E3FC0 @default.
- Q66064366 P31 Q66064366-980BFC37-0CE7-432C-AD4F-65EC180D4121 @default.
- Q66064366 P4135 Q66064366-FAE9B354-2CDD-4A00-B739-BC12C66F9FF0 @default.
- Q66064366 P580 Q66064366-F6880F72-508E-4533-B6F4-660F7DA91C8D @default.
- Q66064366 P582 Q66064366-303D3A24-2A9E-4521-A3D2-B421A6320765 @default.
- Q66064366 P6099 Q66064366-EE666A5A-00C2-4E91-AC79-B2E5D1B15957 @default.
- Q66064366 P6153 Q66064366-7DAB0931-0D5F-42BC-ADAF-F2E2EB6952E8 @default.
- Q66064366 P8363 Q66064366-C7F879B3-A9C0-4670-B22F-85EF1EAD7E08 @default.
- Q66064366 P859 Q66064366-5AAB44E1-B420-4466-B19B-8C2EAE0557B6 @default.
- Q66064366 P1132 "+100" @default.
- Q66064366 P1476 "Phase II Study of Pyrotinib in Combination With Capecitabine in Patients With Trastuzumab-resistant HER2-positive Advanced Breast Cancer" @default.
- Q66064366 P2899 "+18" @default.
- Q66064366 P3098 "NCT04001621" @default.
- Q66064366 P31 Q30612 @default.
- Q66064366 P4135 "+70" @default.
- Q66064366 P580 "2019-06-26T00:00:00Z" @default.
- Q66064366 P582 "2021-03-31T00:00:00Z" @default.
- Q66064366 P6099 Q42824440 @default.
- Q66064366 P6153 Q495015 @default.
- Q66064366 P8363 Q78089383 @default.
- Q66064366 P859 Q495015 @default.